|
|
(+)-endo-6-(4-Fluorophenyl)-4-(propionyloxy)-1-azabicyclo[3.3.1]non-6-ene hydrochloride; (+)-(4R*,5S*)-6-(4-Fluorophenyl)-4-(propionyloxy)-1-azabicyclo[3.3.1]non-6-ene hydrochloride |
|
C17H20FNO2.ClH |
 |
2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
144060-53-7 |
C16H16N2O3S |
 |
1-(3,5-Di-tert-butyl-4-hydroxyphenyl)pyrrolidin-2-one |
129464-78-4 |
C18H27NO2 |
|
|
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-(2’R,5’S)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
134678-17-4; 131086-21-0 (cis-isomer) |
C8H11N3O3S |
|
|
N-[2-(4-Hydroxyphenylamino)-3-pyridyl]-4-methoxybenzenesulfonamide |
141430-65-1; 141450-48-8 (monoHCl) |
C18H17N3O4S |
|
|
[6R-[6alpha,7beta(Z)]]-1-[[7-[[(5-Amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1H-imidazo[1,2-b]pyridazinium chloride; (6R,7R)-7-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2(Z)-(methoxyim |
125905-00-2; 113981-44-5 (former CAS); 113359-04-9 |
C19H17N9O5S2.ClH |
|
|
(+)-(R)-10-Methyl-7-(5-methyl-1H-imidazol-4-ylmethyl)-6,7,8,9-tetrahydropyrido[1,2-a]indol-6-one hydrochloride |
129299-89-4 ((-)-enantiomer, free base); 129299-88 |
C18H19N3O.ClH |
|
|
(-)-(4S)-3-[2(S)-[N-[1(S)-(Ethoxycarbonyl)-3-phenylpropyl]amino]propionyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid hydrochloride; (-)-3-[N-[1(S)-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-1-methyl-2-oxoimidazolidine-4(S)-carboxylic acid hydrochlori |
089396-94-1; 089371-37-9 (free base) |
C20H27N3O6.ClH |
|
|
N-(endo-3,9-Dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl)-1H-indazole-3-carboxamide dihydrochloride |
160472-97-9; 141549-75-9 (free base) |
C17H23N5O.2ClH |
|
|
2-Ethyl-4-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethoxy]quinoline hydrochloride |
135015-84-8 (monoHCl) |
C25H21N5O.ClH |
